By Colin Kellaher
Thermo Fisher Scientific's board has approved a new $4 billion stock buyback program.
The Waltham, Mass., Life-sciences giant on Friday said the new program has no expiration date and replaces its prior buyback authorization, which had about $1 billion remaining.
Thermo Fisher, which had 382.5 million shares outstanding as of Sept. 28, sports a market capitalization of nearly $204 billion.
The company shelled out $3 billion to buy back 5.5 million shares during the first nine months of 2024.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
November 15, 2024 08:12 ET (13:12 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments